S&P 500   4,320.06
DOW   33,963.84
QQQ   356.89
3 Blue Chip Safe Havens to Shield Your Portfolio
Wall Street Legend Warns "Mass Bank Run" is Coming (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Out Of This World Stock Alerts! (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
META's Outperformance Last Week Points to Imminent Breakout
S&P 500   4,320.06
DOW   33,963.84
QQQ   356.89
3 Blue Chip Safe Havens to Shield Your Portfolio
Wall Street Legend Warns "Mass Bank Run" is Coming (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Out Of This World Stock Alerts! (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
META's Outperformance Last Week Points to Imminent Breakout
S&P 500   4,320.06
DOW   33,963.84
QQQ   356.89
3 Blue Chip Safe Havens to Shield Your Portfolio
Wall Street Legend Warns "Mass Bank Run" is Coming (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Out Of This World Stock Alerts! (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
META's Outperformance Last Week Points to Imminent Breakout
S&P 500   4,320.06
DOW   33,963.84
QQQ   356.89
3 Blue Chip Safe Havens to Shield Your Portfolio
Wall Street Legend Warns "Mass Bank Run" is Coming (Ad)
Buy The World’s Largest IT Infrastructure Provider For Under $20
3 Stocks That Flourish In The Fall
Out Of This World Stock Alerts! (Ad)
Stock market today: Wall Street inches lower hinting that sustained market sell-off may continue
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
Experts: NVIDIA Now "Too Big to Succeed" (Ad)
Is Jet Blue's Descent Into Penny Stock Territory an Opportunity?
META's Outperformance Last Week Points to Imminent Breakout
NASDAQ:NARI

Inari Medical (NARI) Stock Forecast, Price & News

$63.55
-1.92 (-2.93%)
(As of 09/22/2023 06:55 PM ET)
Compare
Today's Range
$63.28
$65.62
50-Day Range
$55.60
$71.67
52-Week Range
$52.59
$83.84
Volume
399,700 shs
Average Volume
792,342 shs
Market Capitalization
$3.64 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$85.22

Inari Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
34.1% Upside
$85.22 Price Target
Short Interest
Bearish
9.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of Inari Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$8.43 M Sold Last Quarter
Proj. Earnings Growth
725.00%
From $0.04 to $0.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

286th out of 963 stocks

Surgical & Medical Instruments Industry

36th out of 98 stocks


NARI stock logo

About Inari Medical (NASDAQ:NARI) Stock

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

NARI Price History

NARI Stock News Headlines

CFO Mitch Hill Sells 6,500 Shares of Inari Medical Inc
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Inari Medical (NARI) Receives a Hold from Truist Financial
Would Buffett Approve of This Growth Strategy?
Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.
Why Shares of Inari Medical Are Up Thursday
Inari Medical earnings: here's what Wall Street expects
NARI Inari Medical, Inc.
See More Headlines
Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

NARI Company Calendar

Last Earnings
8/02/2023
Today
9/25/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
1,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$85.22
High Stock Price Forecast
$100.00
Low Stock Price Forecast
$65.00
Forecasted Upside/Downside
+34.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-29,270,000.00
Pretax Margin
-2.80%

Debt

Sales & Book Value

Annual Sales
$383.47 million
Book Value
$7.77 per share

Miscellaneous

Free Float
50,527,000
Market Cap
$3.64 billion
Optionable
Not Optionable
Beta
1.00
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Andrew J. HykesMr. Andrew J. Hykes (Age 49)
    CEO, Pres & Director
    Comp: $863.78k
  • Mr. Mitchell C. HillMr. Mitchell C. Hill (Age 64)
    Chief Financial Officer
    Comp: $811.08k
  • Dr. Thomas M. Tu M.D. (Age 50)
    Chief Medical Officer
    Comp: $812.94k
  • Mr. Paul A. Koehn (Age 60)
    Sr. VP of Operations
  • Mr. John Hsu C.F.A.
    VP of Investor Relations
  • Ms. Angela Ahmad
    Gen. Counsel & Sec.
  • Mr. Eric Khairy
    Sr. VP of Marketing
  • Mr. John R. Borrell (Age 56)
    Sr. VP of Sales
  • Ms. Tara Dunn
    Sr. VP of Clinical Affairs & Market Devel.
  • Mr. Brian Strauss
    Sr. VP of Engineering













NARI Stock - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last twelve months. There are currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NARI shares.
View NARI analyst ratings
or view top-rated stocks.

What is Inari Medical's stock price forecast for 2023?

7 brokerages have issued twelve-month target prices for Inari Medical's shares. Their NARI share price forecasts range from $65.00 to $100.00. On average, they predict the company's stock price to reach $85.22 in the next year. This suggests a possible upside of 34.1% from the stock's current price.
View analysts price targets for NARI
or view top-rated stocks among Wall Street analysts.

How have NARI shares performed in 2023?

Inari Medical's stock was trading at $63.56 at the start of the year. Since then, NARI shares have decreased by 0.0% and is now trading at $63.55.
View the best growth stocks for 2023 here
.

When is Inari Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our NARI earnings forecast
.

How were Inari Medical's earnings last quarter?

Inari Medical, Inc. (NASDAQ:NARI) posted its quarterly earnings results on Wednesday, August, 2nd. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.18. The firm had revenue of $119.01 million for the quarter, compared to the consensus estimate of $116.67 million. Inari Medical had a negative trailing twelve-month return on equity of 3.80% and a negative net margin of 3.66%. The business's quarterly revenue was up 28.3% on a year-over-year basis. During the same quarter last year, the business earned ($0.19) EPS.

What guidance has Inari Medical issued on next quarter's earnings?

Inari Medical issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $482.00 million-$492.00 million, compared to the consensus revenue estimate of $483.82 million.

What other stocks do shareholders of Inari Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?

(NARI) raised $110 million in an initial public offering (IPO) on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

What is Inari Medical's stock symbol?

Inari Medical trades on the NASDAQ under the ticker symbol "NARI."

Who are Inari Medical's major shareholders?

Inari Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.13%), Franklin Resources Inc. (4.74%), Alliancebernstein L.P. (4.02%), State Street Corp (3.09%), Brown Advisory Inc. (2.45%) and Credit Suisse AG (2.07%). Insiders that own company stock include Andrew Hykes, Ansbert Gadicke, Donald B Milder, Gilde Healthcare Cooperatieve, Kirk G Nielsen, Mitch C Hill, Mitch C Hill, Presidio Management Group X Ll, Stanley Tang, Thomas Tu and William Hoffman.
View institutional ownership trends
.

How do I buy shares of Inari Medical?

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inari Medical's stock price today?

One share of NARI stock can currently be purchased for approximately $63.55.

How much money does Inari Medical make?

Inari Medical (NASDAQ:NARI) has a market capitalization of $3.64 billion and generates $383.47 million in revenue each year. The company earns $-29,270,000.00 in net income (profit) each year or ($0.30) on an earnings per share basis.

How many employees does Inari Medical have?

The company employs 1,100 workers across the globe.

How can I contact Inari Medical?

Inari Medical's mailing address is 9 Parker Suite 100, Irvine CA, 92618. The official website for the company is www.inarimedical.com. The company can be reached via phone at 877-923-4747 or via email at ir@inarimedical.com.

This page (NASDAQ:NARI) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -